Clinical Trial Update: Determining the Effectiveness of earLy Intensive Versus Escalation Approaches for RRMS [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial is evaluating early intensive versus escalation treatment strategies for relapsing-remitting multiple sclerosis and is currently active…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Relapsing-remitting Multiple Sclerosis

Snippet

Sponsor: The Cleveland Clinic | Conditions: Multiple Sclerosis, Relapsing-Remitting | Phase 4 | Status: ACTIVE_NOT_RECRUITING